Jane Street’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-193,300
| Closed | -$9.35M | – | 6339 |
|
|
2025
Q1 | $9.35M | Buy |
193,300
+131,749
| +214% | +$6.37M | ﹤0.01% | 874 |
|
|
2024
Q4 | $2.38M | Buy |
61,551
+28,693
| +87% | +$1.11M | ﹤0.01% | 1900 |
|
|
2024
Q3 | $1.48M | Sell |
32,858
-136,453
| -81% | -$6.14M | ﹤0.01% | 2821 |
|
|
2024
Q2 | $5.87M | Buy |
169,311
+88,041
| +108% | +$3.05M | ﹤0.01% | 1517 |
|
|
2024
Q1 | $2.35M | Buy |
81,270
+8,339
| +11% | +$241K | ﹤0.01% | 2120 |
|
|
2023
Q4 | $1.67M | Buy |
72,931
+34,425
| +89% | +$789K | ﹤0.01% | 2723 |
|
|
2023
Q3 | $642K | Buy |
38,506
+16,697
| +77% | +$279K | ﹤0.01% | 3356 |
|
|
2023
Q2 | $602K | Sell |
21,809
-34,407
| -61% | -$950K | ﹤0.01% | 3583 |
|
|
2023
Q1 | $1.29M | Buy |
56,216
+325
| +0.6% | +$7.48K | ﹤0.01% | 2526 |
|
|
2022
Q4 | $610K | Buy |
55,891
+45,602
| +443% | +$498K | ﹤0.01% | 3167 |
|
|
2022
Q3 | $87K | Sell |
10,289
-27,667
| -73% | -$234K | ﹤0.01% | 4945 |
|
|
2022
Q2 | $300K | Buy |
+37,956
| New | +$300K | ﹤0.01% | 4095 |
|
|
2022
Q1 | – | Sell |
-76,396
| Closed | -$2.61M | – | 6090 |
|
|
2021
Q4 | $2.61M | Buy |
76,396
+18,542
| +32% | +$634K | ﹤0.01% | 1640 |
|
|
2021
Q3 | $1.03M | Buy |
+57,854
| New | +$1.03M | ﹤0.01% | 2612 |
|
|
2021
Q1 | – | Sell |
-14,473
| Closed | -$292K | – | 5295 |
|
|
2020
Q4 | $292K | Buy |
14,473
+1,205
| +9% | +$24.3K | ﹤0.01% | 3181 |
|
|
2020
Q3 | $259K | Buy |
+13,268
| New | +$259K | ﹤0.01% | 3003 |
|
|
2018
Q3 | – | Sell |
-12,945
| Closed | -$87K | – | 3829 |
|
|
2018
Q2 | $87K | Buy |
+12,945
| New | +$87K | ﹤0.01% | 3078 |
|
|
2016
Q4 | – | Sell |
-10,964
| Closed | -$232K | – | 2956 |
|
|
2016
Q3 | $232K | Buy |
+10,964
| New | +$232K | ﹤0.01% | 2404 |
|